ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,619Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 623

$806K Total Retail Price of All Prescriptions

Rank: 11 out of 623

525 Patients Receiving at Least One Drug in Part D
39%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 525 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 525 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 5,115 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 667 272 1 1
SIMVASTATIN 476 233 2 2
ATORVASTATIN CALCIUM 360 158 3 10
LEVOTHYROXINE SODIUM 339 141 4 4
FUROSEMIDE 338 195 5 5
AMLODIPINE BESYLATE 328 127 6 3
METOPROLOL TARTRATE 324 118 7 9
METFORMIN HCL 311 132 8 6
OMEPRAZOLE 301 92 9 7
RANITIDINE HCL 290 90 10 23
PRAVASTATIN SODIUM 281 135 11 11
HYDROCHLOROTHIAZIDE 273 109 12 8
SPIRIVA 221 98 13 58
WARFARIN SODIUM 207 62 14 14
GABAPENTIN 204 88 15 18
ADVAIR DISKUS 202 46 16 39
ZOLPIDEM TARTRATE 174 57 17 22
TRAMADOL HCL 169 82 18 15
NEXIUM 165 62 19 43
PROAIR HFA 160 47 20 57
FENOFIBRATE 155 45 21 71
HYDROCODONE-ACETAMINOPHEN 145 80 S3 22 17
METOPROLOL SUCCINATE 141 81 23 13
CITALOPRAM HBR 139 81 24 21
OXYCODONE-ACETAMINOPHEN 136 68 S2 25 42
CYCLOBENZAPRINE HCL 131 23 R 26 65
GLIPIZIDE ER 121 49 27 100
CYMBALTA 118 34 28 52
DIOVAN 110 74 29 48
FLUTICASONE PROPIONATE 109 65 30 29
CRESTOR 109 57 30 28
VENTOLIN HFA 107 16 32 92
GLIPIZIDE XL 106 44 33 126
LIPITOR 104 67 34 127
OXYCODONE HCL 93 26 S2 35 30
LANTUS 92 40 36 41
ATENOLOL 91 18 37 12
NIASPAN 91 35 37 123
ESCITALOPRAM OXALATE 88 52 39 60
ROPINIROLE HCL 81 37 40 111
PANTOPRAZOLE SODIUM 80 57 41 26
ZETIA 80 46 41 99
GLIPIZIDE 72 30 43 33
CARVEDILOL 72 33 43 32
CLOPIDOGREL 70 40 45 34
SERTRALINE HCL 64 18 46 20
TRAZODONE HCL 63 29 47 36
HYDROXYZINE HCL 62 0 R 48 187
PLAVIX 61 36 49 46
QUINAPRIL HCL 60 27 50 138
LOVASTATIN 60 16 50 25
NOVOLOG MIX 70-30 FLEXPEN 59 37 52 191
ACTOS 58 23 53 128
SINGULAIR 57 0 54 109
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 23 55 19
LANSOPRAZOLE 54 14 56 147
TAMSULOSIN HCL 54 28 56 35
DILTIAZEM 24HR ER 52 0 58 198
LYRICA 52 13 58 86
JANUVIA 51 16 60 87
PAROXETINE HCL 50 17 61 66
IBUPROFEN 50 0 61 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.